# FDA Adopts SI Terminology

Under Executive Order 14434, the FDA begins using “Super Intelligence” and “SI” instead of “Artificial Intelligence” and “AI” in applicable non-statutory communications in newly issued public-facing materials starting November 16, 2026. The notice creates no new requirements for FDA submitters and identifies no new procurement funding or contract requirements; forms, templates, databases, and web content will be updated on their normal maintenance cycles.

- Contractors supporting FDA communications or content may need to use the revised terminology in applicable new materials.
- The change is a terminology update, not a new deliverable, compliance obligation, or funding opportunity; the notice does not identify new contract requirements.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Policy
**Published:** November 16, 2026

### Government Entities
- U.S. Food and Drug Administration (FDA)
- Executive departments and agencies

### Sources
- [FDA’s Use of “Super Intelligence” and “SI” Under Executive Order 14434 | FDA](https://www.fda.gov/science-research/fda-and-super-intelligence/fdas-use-super-intelligence-and-si-under-executive-order-14434) - FDA